NCT05862844

Promise Women Project

Completed NA Results posted Last updated 7 November 2024

What this trial tests

NA trial testing Promise women project (Promote Cervical Cancer Prevention Methods Among Muslim Women in Virginia ) in Human Papilloma Virus in 20 participants. Completed in 15 October 2023.

Timeline

25 September 2023

Primary endpoint
15 October 2023

15 October 2023

Quick facts

Lead sponsor	Mark Dignan, PhD
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	20
Start date	25 September 2023
Primary completion	15 October 2023
Estimated completion	15 October 2023
Sites	4 locations across United States

Drugs / interventions tested

• Promise women project (Promote Cervical Cancer Prevention Methods Among Muslim Women in Virginia )

Conditions studied

• Human Papilloma Virus — all drugs for Human Papilloma Virus →
• Cervical Cancer — all drugs for Cervical Cancer →

Sponsor

Mark Dignan, PhD

Who can join

18 and older, female only, with Human Papilloma Virus or Cervical Cancer. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Number of Women Who Undergo Cervical Cancer Screening. Primary · Baseline and Post Intervention (up to 1 week)

measured by tracking the number of women who schedule and attend

Group	Value	95% CI
The Single-arm Trial With a Pre- and Post-test Design	20

Number of Women Enrolled Secondary · Baseline and Post Intervention (up to 1 week)

Test the intervention program's feasibility as evidenced by meeting enrollment targets

Group	Value	95% CI
The Single-arm Trial With a Pre- and Post-test Design	20

Number of Women That Attend the Education Session Secondary · Baseline and Post Intervention (up to 1 week)

Test the intervention program's acceptability as evidenced by session attendance

Group	Value	95% CI
The Single-arm Trial With a Pre- and Post-test Design	20

Sponsor's own description

The goal of this study is to develop and test an intervention program to improve cervical cancer prevention among Muslim American women. The main questions the investigators aim to answer are:

* Will the religiously tailored and culturally appropriate intervention program improve participants' knowledge and acceptance of cervical cancer prevention?
* Is the intervention program feasible to conduct and acceptable to participants?

Participants will be asked to:

* Attend focus group sessions to provide input on the development of educational materials.
* Complete pre- and post-intervention surveys to measure changes in knowledge and acceptance of cervical cancer prevention.
* Engage in the intervention program, which includes education and experiential practice/communication skills training.
* Provide feedback through satisfaction surveys. Researchers will compare participant outcomes before and after the intervention to assess its effectiveness. Additionally, the program's feasibility and acceptability will be evaluated based on enrollment rates, successful implementation, participant engagement, retention, and satisfaction.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. A Pilot Study: Adaptation Phase of the PROMIS Women Education Program-Promoting Cervical Cancer Prevention Methods Among Muslim Women in Virginia.
   Namoos A, Abosamak N, Sheppard V. · · 2025 · PMID 41070963 · DOI 10.1002/cam4.71296